Berend Jan Van Keulen

Title: Berend Jan Van Keulen: Innovator in Pharmaceutical Chemistry

Introduction

Berend Jan Van Keulen, based in Tubize, Belgium, is a prominent inventor in the field of pharmaceutical chemistry. With a total of three patents to his name, he has made significant contributions to the development of innovative chemical compounds.

Latest Patents

Among his latest inventions, Van Keulen's patented work includes "Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions." This innovation focuses on chemical compounds that exhibit both affinity and antagonism against the human m3 muscarinic receptor, while also serving as selective phosphodiesterase IV (PDE IV) inhibitors. The patent discusses processes for preparing these compounds, along with the pharmaceutical compositions containing them, aimed at enhancing their utility in medical applications.

Another noteworthy patent by Van Keulen is for "Substituted cyclopropylamino-1,3,5-triazines," which introduces new substituted cyclopropylamino-1,3,5-triazines characterized by specific chemical formulas. This innovation opens up avenues for further research and applications in pharmaceuticals.

Career Highlights

Berend Jan Van Keulen is currently affiliated with UCB S.A., a global biopharmaceutical company known for its innovative research and development efforts. His work at UCB emphasizes the importance of advancing drug treatment options and improving patient care through innovative chemical solutions.

Collaborations

Throughout his career, Van Keulen has collaborated with several talented colleagues, including fellow inventors Solo Goldstein and Eric Cossement. These partnerships have fostered an environment of creativity and innovation, resulting in significant advancements in pharmaceutical chemistry.

Conclusion

Berend Jan Van Keulen stands out as a leading inventor whose contributions to chemical compounds and pharmaceutical compositions have the potential to drive advancements in medical science. With an impressive track record of patents and collaborations, he continues to play a vital role in the evolution of pharmaceuticals, offering promising solutions for future healthcare challenges.